317 related articles for article (PubMed ID: 27573661)
1. HIV Infection and Survival Among Women With Cervical Cancer.
Dryden-Peterson S; Bvochora-Nsingo M; Suneja G; Efstathiou JA; Grover S; Chiyapo S; Ramogola-Masire D; Kebabonye-Pusoentsi M; Clayman R; Mapes AC; Tapela N; Asmelash A; Medhin H; Viswanathan AN; Russell AH; Lin LL; Kayembe MKA; Mmalane M; Randall TC; Chabner B; Lockman S
J Clin Oncol; 2016 Nov; 34(31):3749-3757. PubMed ID: 27573661
[TBL] [Abstract][Full Text] [Related]
2. HIV infection is not associated with the initiation of curative treatment in women with cervical cancer in Botswana.
Grover S; MacDuffie EC; Wang Q; Bvochora-Nsingo M; Bhatia RK; Balang D; Chiyapo SP; Luckett R; Ramogola-Masire D; Dryden-Peterson SL; Lin LL; Shin SS; Zetola NM
Cancer; 2019 May; 125(10):1645-1653. PubMed ID: 30801696
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of chemoradiotherapy in cervical cancer--the Western Australian experience.
Lim A; Sia S
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1431-8. PubMed ID: 21640504
[TBL] [Abstract][Full Text] [Related]
4. Californium-252 neutron brachytherapy combined with external pelvic radiotherapy plus concurrent chemotherapy for cervical cancer: a retrospective clinical study.
Qian S; Ye L; Tian YH; Wang LG; Huang ZP; Li F; Hou B; Song N; Chen J; Liu Y; Liu X; Zhou T
Chin J Cancer; 2017 Feb; 36(1):24. PubMed ID: 28245859
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin and radiation therapy in HIV-positive women with locally advanced cervical cancer in sub-Saharan Africa: A phase II study of the AIDS malignancy consortium.
Einstein MH; Ndlovu N; Lee J; Stier EA; Kotzen J; Garg M; Whitney K; Lensing SY; Tunmer M; Kadzatsa W; Palefsky J; Krown SE
Gynecol Oncol; 2019 Apr; 153(1):20-25. PubMed ID: 30773222
[TBL] [Abstract][Full Text] [Related]
6. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
7. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F
BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.
Ho JC; Allen PK; Bhosale PR; Rauch GM; Fuller CD; Mohamed AS; Frumovitz M; Jhingran A; Klopp AH
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):546-553. PubMed ID: 28011045
[TBL] [Abstract][Full Text] [Related]
9. Brachytherapy should not be omitted when treating locally advanced neuroendocrine cervical cancer with definitive chemoradiation therapy.
Robin TP; Amini A; Schefter TE; Behbakht K; Fisher CM
Brachytherapy; 2016; 15(6):845-850. PubMed ID: 27720204
[TBL] [Abstract][Full Text] [Related]
10. Impact of Human Immunodeficiency Virus Infection on Survival and Acute Toxicities From Chemoradiation Therapy for Cervical Cancer Patients in a Limited-Resource Setting.
Grover S; Bvochora-Nsingo M; Yeager A; Chiyapo S; Bhatia R; MacDuffie E; Puri P; Balang D; Ratcliffe S; Narasimhamurthy M; Gwangwava E; Tsietso S; Kayembe MKA; Ramogola-Masire D; Dryden-Peterson S; Mahantshetty U; Viswanathan AN; Zetola NM; Lin LL
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):201-210. PubMed ID: 29619965
[TBL] [Abstract][Full Text] [Related]
11. Distant metastasis in patients with cervical cancer after primary radiotherapy with or without chemotherapy and image guided adaptive brachytherapy.
Schmid MP; Franckena M; Kirchheiner K; Sturdza A; Georg P; Dörr W; Pötter R
Gynecol Oncol; 2014 May; 133(2):256-62. PubMed ID: 24517875
[TBL] [Abstract][Full Text] [Related]
12. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
13. Benefit of Cisplatin With Definitive Radiotherapy in Older Women With Cervical Cancer.
Xiang M; Kidd EA
J Natl Compr Canc Netw; 2019 Aug; 17(8):969-975. PubMed ID: 31390586
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally advanced cervical cancer.
Novetsky AP; Einstein MH; Goldberg GL; Hailpern SM; Landau E; Fields AL; Mutyala S; Kalnicki S; Garg M
Gynecol Oncol; 2007 Jun; 105(3):635-40. PubMed ID: 17331568
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
Castelnau-Marchand P; Chargari C; Maroun P; Dumas I; Del Campo ER; Cao K; Petit C; Martinetti F; Tafo-Guemnie A; Lefkopoulos D; Morice P; Haie-Meder C; Mazeron R
Gynecol Oncol; 2015 Nov; 139(2):288-94. PubMed ID: 26364808
[TBL] [Abstract][Full Text] [Related]
16. Concomitant cisplatin plus radiotherapy and high-dose-rate brachytherapy versus radiotherapy alone for stage IIIB epidermoid cervical cancer: a randomized controlled trial.
Zuliani AC; Esteves SC; Teixeira LC; Teixeira JC; de Souza GA; Sarian LO
J Clin Oncol; 2014 Feb; 32(6):542-7. PubMed ID: 24449243
[TBL] [Abstract][Full Text] [Related]
17. Carboplatin-based chemoradiotherapy in advanced cervical cancer: an alternative to cisplatin-based regimen?
Sebastião AM; da Silva Rocha LS; Gimenez RD; de Barros LA; Fukushima JT; da Silva SC; da Costa Miranda V; de Souza Caires IQ; de Freitas D; Filho EA; Diz Mdel P
Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():161-5. PubMed ID: 27137353
[TBL] [Abstract][Full Text] [Related]
18. Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy.
Rijkmans EC; Nout RA; Rutten IH; Ketelaars M; Neelis KJ; Laman MS; Coen VL; Gaarenstroom KN; Kroep JR; Creutzberg CL
Gynecol Oncol; 2014 Nov; 135(2):231-8. PubMed ID: 25172763
[TBL] [Abstract][Full Text] [Related]
19. Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer.
Cihoric N; Tsikkinis A; Tapia C; Aebersold DM; Zlobec I; Lössl K
Radiat Oncol; 2015 Nov; 10():240. PubMed ID: 26597282
[TBL] [Abstract][Full Text] [Related]
20. Association Between CD4 Count and Chemoradiation Therapy Outcomes Among Cervical Cancer Patients With HIV.
Grover S; Mehta P; Wang Q; Bhatia R; Bvochora-Nsingo M; Davey S; Iyengar M; Shah S; Shin SS; Zetola NM
J Acquir Immune Defic Syndr; 2020 Oct; 85(2):201-208. PubMed ID: 32568769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
